TRINITY BIOTECH PLC Deferred Tax Expense Income
TRINITY BIOTECH PLC (TRIB) reported Deferred Tax Expense Income of $201.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-05-16.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:DeferredTaxExpenseIncome · last filed 2025-05-16
| Period end | Deferred Tax Expense Income 12 month | Deferred Tax Expense Income 12 month as first filed |
|---|---|---|
| 2024-12-31 | $201.00K 20-F · filed 2025-05-16 | |
| 2023-12-31 | -$323.00K 20-F · filed 2025-05-16 | |
| 2022-12-31 | $86.00K 20-F · filed 2025-05-16 | $83.00K 20-F · filed 2023-05-16 |
| 2021-12-31 | $37.00K 20-F · filed 2024-04-30 | |
| 2020-12-31 | -$167.00K 20-F · filed 2023-05-16 | |
| 2019-12-31 | -$841.00K 20-F · filed 2022-05-02 | |
| 2018-12-31 | -$406.00K 20-F · filed 2021-04-30 | |
| 2017-12-31 | -$1.67M 20-F · filed 2020-06-15 | |
| 2016-12-31 | -$3.27M 20-F · filed 2019-05-14 | |
| 2015-12-31 | $453.00K 20-F · filed 2018-04-20 |